UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Drinking milk daily cuts breast cancer risk considerably’
A recent study conducted by Seoul National University has found that drinki...
by Shim Hyun-tai
|
2020-01-14 07:44
라인
GSK shows meaningful response rate for treatment of multiple myeloma
GSK Korea said that treatment with the investigational single-agent belanta...
by Lee Han-soo
|
2020-01-13 17:48
라인
Mundipharma to commercialize Samsung Bioepis’ biosimilar in Hong Kong, Taiwan
Mundipharma said that it has entered into a partnership with Samsung Bioepi...
by Lee Han-soo
|
2020-01-13 16:23
라인
Vivozon positive of Opiranserin’s efficacy despite failures to meet primary endpoint
Vivozon said that it has started on a design change for its phase 3b clinic...
by Lee Han-soo
|
2020-01-13 16:22
라인
[CES 2020] Digital therapeutics to change the standard of care
Digital therapeutics was one of the hot topics during this year's Consu...
by Lee Han-soo
|
2020-01-13 14:06
라인
Korea reports 1st case of mysterious pneumonia
The Korea Centers for Disease Control and Prevention (KCDC) said that it ha...
by Lee Han-soo
|
2020-01-08 18:12
라인
HLB gets UAE’s nod for joint company with local partner
Elevar therapeutics, a U.S. subsidiary of HLB, said that the United Arab Em...
by Lee Han-soo
|
2020-01-08 16:31
라인
Daewoong, Avacta to establish joint venture
Daewoong Pharmaceutical said that it plans to set up a joint venture (JV) w...
by Lee Han-soo
|
2020-01-08 12:25
라인
Genexine licenses out immunosuppressant candidate to GenNBio
Genexine said that it has licensed out BSF-110, a dual-fusion immunosuppres...
by Lee Han-soo
|
2020-01-07 17:35
라인
Mundipharma to market Biosolution's knee cartilage defect treatment
Biosolution said that it has signed an exclusive sales agreement with Mundi...
by Lee Han-soo
|
2020-01-07 16:11
라인
Fenbendazole craze expands to human parasiticide
Following the craze over fenbendazole, a dog deworming drug, in treating ca...
by Lee Han-soo
|
2020-01-07 12:33
라인
Nurse confirms smartwatch helpful in conducting CPR
A nurse from Chung-Ang University Medical Center (CAUMC) has confirmed that...
by Lee Han-soo
|
2020-01-06 17:22
라인
Koreans OK with sharing private medical info for better public health
Nearly eight out of 10 Koreans are willing to share their biodata for incre...
by Lee Han-soo
|
2020-01-06 16:45
라인
Lunit raises ₩30 billion in Series C funding
Lunit said that it has attracted investment of 30 billion won ($25.6 millio...
by Lee Han-soo
|
2020-01-06 15:07
라인
Chinese drugmaker Mebo establishes branch in Korea
Mebo Group, a Chinese firm specializing in regenerative medicine, has estab...
by Lee Han-soo
|
2020-01-06 14:40
라인
Bukwang, Sanofi Aventis Korea to co-promote hypertension med
Bukwang Pharmaceutical said that it would promote and market Aprovel and Co...
by Lee Han-soo
|
2020-01-03 17:55
라인
Daewoong launches oral typhoid fever vaccine
Daewoong Pharmaceutical said that it has launched Vivotif, an oral typhoid ...
by Lee Han-soo
|
2020-01-03 17:55
라인
[New Year Special] Rise of digital therapeutics to change healthcare scene for good
If a person gets sick, he or she visits a doctor, gets a prescription, take...
by Lee Han-soo
|
2020-01-03 14:57
라인
SK Bioscience’s influenza vaccine nabs WHO certification
SK Bioscience said that the World Health Organization (WHO) has granted pre...
by Lee Han-soo
|
2020-01-03 14:14
라인
Daewoong to kick off P3 trial of Nabota in China
Daewoong Pharmaceutical said Tuesday that it held a meeting with Chinese re...
by Lee Han-soo
|
2020-01-02 17:36
-
이전
21
22
23
24
25
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top